The litigation targets Zoetis and its leadership, questioning whether the company engaged in unlawful business practices that misled shareholders. The scrutiny follows a tumultuous May 7, 2026, earnings report where the company revealed stagnant net income of $601 million and lowered its annual profit guidance to between $6.85 and $7 per share.
In section Releases
Zoetis Faces Class Action Lawsuit Following Earnings Miss
Investors who suffered losses in Zoetis Inc. stock are being urged to join a class action lawsuit filed by Pomerantz LLP. The legal action stems from allegations of securities fraud following a sharp decline in the company’s share price earlier this year, with a July 27, 2026, deadline for lead plaintiff applications.
During that session, CEO Kristin Peck attributed the lackluster performance to a difficult operating environment, noting that pet owners were becoming increasingly price-sensitive, which led to fewer veterinary visits. The market reacted sharply to the revised projections, sending Zoetis shares tumbling $23.91—a 21.5% drop—to close at $87.31. Investors looking to participate in the class action or seeking further information regarding the complaint are directed to contact Danielle Peyton at Pomerantz LLP.
Comments (0)
No comments yet. Be the first!